MedPath

Supermicrosurgical Lymphvenous Bypass Intervention for Treatment

Conditions
Lymphedema of Leg
Registration Number
NCT05270629
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic flow. However, this concept has yet to be validated. The aim of this study was to determine the impacts on outcomes of performing both retrograde and antegrade anastomosis, as compared to antegrade-only anastomosis for treating lower limb lymphedema.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Lower limb lymphedema patients.
Exclusion Criteria
  • Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Magnetic resonance volumetry6 months after LVA

Magnetic resonance volumetry was used for outcome assessments. The primary endpoint was the volume change at 6 months after LVA.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Kaohsiung Chang Gung Memorial Hospital
🇨🇳Kaohsiung, Taiwan
Hsiao-Yun Hsieh, MSc
Contact
+886-7-7317123
sylvia19870714@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.